If it helps manage and prevent those life-threatening risks, then for that patient it is probably better to continue it. The TGA said it first became aware of the link to NAION in 2024 after a study published in a peer-reviewed medical journal raised concerns, and further evidence of the potential links has since been closely monitored
Without any of those, you pay full retail, which is over $12,000 per year
If youve lost significant weight with GLP-1 medications and want to address loose skin without scars, schedule an in-person or virtual consultation with Dr
The absence of a patient information leaflet, dosing guidance, or medical supervision makes self-administration of bulk-sourced retatrutide inherently unsafe
Based on the current stage of clinical development and estimated trial completion dates registered on ClinicalTrials.gov, a realistic earliest possible timeline might be considered as follows: 20252026: Completion of key phase 3 TRIUMPH trial data 20262027: Potential regulatory submission to the MHRA (and FDA/EMA in parallel) 20272028: Possible MHRA marketing authorisation, subject to satisfactory review 2028 onwards: NICE technology appraisal and potential NHS commissioning decision These timelines are speculative and depend on multiple variables, including trial outcomes, the completeness of the regulatory submission, MHRA review timelines, and NICE deliberations
The company provides simple packaging and fast shipping